Asia Pacific HIV Diagnostics Market
- 2026 年市場規模
- USD 1.32 Bn
- 2033 年預估規模
- USD 2.67 Bn
- 年複合成長率 CAGR
- 10.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Asia Pacific HIV Diagnostics Market, By Product Type (Instruments, Reagents & Kits), By Test Type (Screening (Third Generation ,Fourth Generation), Differentiation & Confirmation Test, Monitoring Test (CD4 Tests, Viral Load Tests), By End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), By Geography (China, Japan, South Korea, ASEAN, India, Australia, and Rest of Asia Pacific)
報告摘要
HIV causes AIDS and interferes with the body's ability to fight infections. The virus can be transmitted through contact with infected blood, semen or vaginal fluids. Within a few weeks of HIV infection, flu-like symptoms such as fever, sore throat and fatigue can occur. Then the disease is usually asymptomatic until it progresses to AIDS. AIDS symptoms include weight loss, fever or night sweats, fatigue and recurrent infections. HIV (human immunodeficiency virus) is a virus that attacks cells that help the body fight infection, making a person more vulnerable to other infections and diseases. HIV can be diagnosed through blood or saliva testing. Available tests include: Antigen/antibody tests. These tests usually involve drawing blood from a vein. Antigens are substances on the HIV virus itself and are usually detectable — a positive test — in the blood within a few weeks after exposure to HIV. According to the Center for Disease Control and Prevention, three types of HIV tests are available:
• Nucleic acid tests (NATs) — detects HIV ribonucleic acid (RNA)
• Antigen/antibody combination tests — detects HIV p24 antigen as well as HIV immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies
• Antibody tests — detects HIV IgM and/or IgG antibodies
The time between potential HIV exposure and an accurate test result is referred to as the window period. Improvements in testing technology continue to reduce the detection window period, and, therefore, the time to diagnosis and treatment of early HIV infection.
Market Dynamics
Increasing engagement programs by various government bodies to reduce disease burden of HIV epidemics and growing need for safe blood transfusion and donations in Asia Pacific is expected to drive the HIV diagnostic market size during the forecast period. For instance, in January 2018, India plans to make pre-exposure prophylaxis (PrEP) available to men who have sex with men (MSM) and transgender women. The Indian Council of Medical Research (ICMR) indicated in November 2018 that it is planning to study the effectiveness of PrEP in high-risk groups.
However, stigma and social ostracism associated with HIV infections and diseases is expected to hinder the timely HIV diagnostics and treatment. Moreover, the fear of being tested positive, discrimination, rejection, and stigma restricts several people from conducting screening voluntarily. The fear of discord in marital relationships is yet another challenge where testing HIV positive is often seen as a case of infidelity. Therefore, these factors are expected to hamper the market growth.
Key features of the study
• This report provides an in-depth analysis of the Asia Pacific HIV diagnostics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Asia Pacific HIV diagnostics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche AG, Atomo diagnostics, Siemens Healthineers, Inc., bioLytical Laboratories Inc., MedMira Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Danaher Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Asia Pacific HIV diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Asia Pacific HIV diagnostics market
Market Segmentation
• Product Type Insights (Revenue, USD Bn, 2026 - 2033)
o Instruments
o Reagents & Kits
• Test Type Insights (Revenue, USD Bn, 2026 - 2033)
o Screening
Third Generation
Fourth Generation
o Differentiation & Confirmation Test
o Monitoring Test
CD4 Tests
Viral Load Tests
• End User Insights (Revenue, USD Bn, 2026 - 2033)
o Hospitals and Clinics
o Diagnostic Laboratories
o Home Care Settings
o Others
• Country Insights (Revenue, USD Bn, 2026 - 2033)
o Japan
o China
o South Korea
o ASEAN
o Australia
o India
o Rest of Asia Pacific
• Key Players Insights
o Abbott Laboratories
o Merck KGaA
o F. Hoffmann-La Roche AG
o Atomo Diagnostics
o Siemens Healthineers, Inc.
o bioLytical Laboratories Inc.
o MedMira Inc.
o Becton, Dickinson and Company
o Bio-Rad Laboratories, Inc.
o Danaher Corporation
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Asia Pacific HIV Diagnostics Market, By Product Type
Asia Pacific HIV Diagnostics Market, By Test Type
Asia Pacific HIV Diagnostics Market, By End User
Asia Pacific HIV Diagnostics Market, By Country
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trend
4. Asia Pacific HIV Diagnostics Market, By Product Type, 2020-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Instruments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Reagents & Kits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
5. Asia Pacific HIV Diagnostics Market, By Test Type, 2020-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Screening
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Segment Trends
o Third Generation
o Fourth Generation
o Differentiation & Confirmation Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Monitoring Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Segment Trends
o CD4 Tests
o Viral Load Tests
6. Asia Pacific HIV Diagnostics Market, By End User, 2020-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
7. Asia Pacific HIV Diagnostics Market, By Country, 2020 - 2033, Value (USD Bn)
o Introduction
Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
Country Trends
o Japan
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Test Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
o China
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Test Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
o South Korea
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Test Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
o ASEAN
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Test Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
o Australia
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Test Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
o India
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Test Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
o Rest of Asia Pacific
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By Test Type, 2020 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
8. Competitive Landscape
o Abbott Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Merck KGaA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o F. Hoffmann-La Roche AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Atomo Diagnostics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Siemens Healthineers, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o bioLytical Laboratories Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o MedMira Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Becton, Dickinson and Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bio-Rad Laboratories, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Danaher Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
10. References and Research Methodology
o References
o Research Methodology
o About us
提及公司
同分類最新報告（醫療器材）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們